#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting

#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting

Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online

La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h

#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online

#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting

Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:

#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting

#IDIBELLfellows: Francisco José López-Murcia

The Presynaptic Dimension of Brain Pathologies: from the Neurotransmitter Release Machinery to Microcircuits Francisco José López-Murcia Cellular…

Read More

Aprendre biomedicina amb un escape room virtual?

Comunicació científica – Taller: ‘Aprendre biomedicina amb un escape room virtual?’ T’agradaria aprendre recerca biomèdica tot jugant…

Read More

#IDIBELLseminars: Theranostics with radiopharmaceuticals: Quo Vadis

The term theranostics has clearly become a buzzword. To a large extent, this is due to the…

Read More

Empowering Public Health: European Network for Smoking and Tobacco Prevention as a Key Stakeholder in the Tobacco Control Ecosystem

by Karina Mocanu When: Tuesday 6th of June. From 12.30 to 13.30 h Where: Aula Jardí –…

Read More

Sessió de recerca i lliurament dels ajuts de recerca

Comitè de recerca – Hospital Universitari de Bellvitge Sala d’actes de l’HUB, dijous 29 de juny2023,  a…

Read More

Immunoprevention in Lynch syndrome

Tuesday 13 June. 12h. Aula Pau Viladiu. Immunoprevention in Lynch syndrome Eduardo Vilar-Sánchez – Department of Clinical…

Read More

NeuroDebate 2023

Viernes 09 de junio 2023 (16:00-19:15) Sábado 10 de junio 2023 (10:00-13:00) Sala de Grados de la…

Read More

#IDIBELLseminars: Engineering a potent T-cell response against solid tumors

The success of T-cell therapies for solid tumors has been limited, among others, by the scarcity of…

Read More

#IDIBELLfellows: Adrian Martinez Tebar / Ferran Medina

The role of ROS metabolism and pseudohypoxia in antiandrogen resistance Adrián Martínez Resistance and Progression Mechanisms in…

Read More

Pint of Science

Datos y datos contra el Cáncer Hereditario. Elisabet Munté Roca – IDIBELL Hereditary Cancer research group. 22/05/2023….

Read More
Scroll to Top